MicrobiologybioRxivPreprint
An ACE2-blocking antibody confers broad neutralization and protection against Omicron and other SARS-CoV-2 variants
DOI 10.1101/2022.02.17.480751
Author
R. van Haperen
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
Biology Disciplines
Click to filter author papersSignature Assays, Organisms & Methods
Click to filter · or open tagActivity by Year
2020-2022 · peak 2/yrCo-Author Collaboration Network
10 top collaborators · 43 mutual co-author linksFocal author (center)Selected co-authorORCID co-authorUnlinked name
Curved chords = mutual co-authorship3 papers
Recent·Most cited
- MicrobiologybioRxivPreprint
Isolation of cross-reactive monoclonal antibodies against divergent human coronaviruses that delineate a conserved and vulnerable site on the spike protein
C. Wang, R. van Haperen, J. Gutierrez-Alvarez…·B.-J. Bosch
This study isolates two cross-reactive monoclonal antibodies against multiple Betacoronaviruses, identifying a conserved vulnerable site on the spike protein.
DOI 10.1101/2020.10.20.346916 - MicrobiologybioRxiv
A human monoclonal 1 antibody blocking SARS-CoV-2 infection
C. Wang, W. Li, D. Drabek…·B.-J. Bosch
This paper reports a human monoclonal antibody that neutralizes SARS-CoV-2 and SARS-CoV, targeting a shared epitope for potential prevention and treatment of COVID-19.
DOI 10.1038/s41467-020-16256-y